Randomized phase III trial of conventional paclitaxel and carboplatin (c-TC) versus dose dense weekly paclitaxel and carboplatin (dd-TC) in women with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: Japanese Gynecologic Oncology

S. Isonishi; M. Yasuda; F. Takahashi; N. Katsumata; E. Kimura; D. Aoki; T. Jobo; F. Terauchi; H. Tsuda; T. Sugiyama

doi:10.1200/jco.2008.26.15_suppl.5506

Randomized phase III trial of conventional paclitaxel and carboplatin (c-TC) versus dose dense weekly paclitaxel and carboplatin (dd-TC) in women with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: Japanese Gynecologic Oncology

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.5506 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 5506-5506 ◽

Cited By ~ 18

Author(s):

S. Isonishi ◽

M. Yasuda ◽

F. Takahashi ◽

N. Katsumata ◽

E. Kimura ◽

...

Keyword(s):

Fallopian Tube ◽

Gynecologic Oncology ◽

Phase Iii ◽

Weekly Paclitaxel ◽

Phase Iii Trial ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Dose Dense

Download Full-text

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1016/j.ygyno.2005.11.013 ◽

2006 ◽

Vol 100 (1) ◽

pp. 27-32 ◽

Cited By ~ 227

Author(s):

Joan L. Walker ◽

Deborah K. Armstrong ◽

Helen Q. Huang ◽

Jeffrey Fowler ◽

Kenneth Webster ◽

...

Keyword(s):

Intraperitoneal Chemotherapy ◽

Gynecologic Oncology ◽

Phase Iii ◽

Stage Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

Relationship between ERCC1 polymorphisms, disease progression, and survivalin GOG0182, a Gynecologic Oncology Group phase III trial of platinum-based chemotherapy in women with advanced stage epithelial ovarian or primary peritoneal cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.5540 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 5540-5540

Author(s):

T. C. Krivak ◽

K. M. Darcy ◽

C. Tian ◽

M. A. Bookman ◽

B. A. Baysal ◽

...

Keyword(s):

Disease Progression ◽

Gynecologic Oncology ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Advanced Stage ◽

Oncology Group ◽

Phase Iii Trial ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Platinum Based Chemotherapy

Download Full-text

ICON8: An international randomized trial comparing two dose-dense regimens, 3-weekly carboplatin plus weekly paclitaxel (CwT), and weekly carboplatin-paclitaxel (wCwT), to standard 3-weekly treatment in women with newly diagnosed ovarian, fallopian tube, and primary peritoneal cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.tps5611 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. TPS5611-TPS5611 ◽

Cited By ~ 2

Author(s):

Jane Hook ◽

Sally Patricia Stenning ◽

James Brenton ◽

Stan B Kaye ◽

Iain A. McNeish ◽

...

Keyword(s):

Randomized Trial ◽

Fallopian Tube ◽

Weekly Paclitaxel ◽

Newly Diagnosed ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Weekly Treatment ◽

Dose Dense

Download Full-text

A phase II evaluation of elesclomol sodium and weekly paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube or primary peritoneal cancer: An NRG oncology/gynecologic oncology group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2018.10.001 ◽

2018 ◽

Vol 151 (3) ◽

pp. 422-427 ◽

Cited By ~ 7

Author(s):

Bradley J. Monk ◽

James T. Kauderer ◽

Katherine M. Moxley ◽

Albert J. Bonebrake ◽

Summer B. Dewdney ◽

...

Keyword(s):

Fallopian Tube ◽

Phase Ii ◽

Gynecologic Oncology ◽

Weekly Paclitaxel ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Platinum Resistant

Download Full-text

Re: Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study.

Gynecologic Oncology ◽

10.1016/j.ygyno.2006.02.021 ◽

2006 ◽

Vol 102 (1) ◽

pp. 129 ◽

Cited By ~ 1

Author(s):

E. Petru ◽

Ch. Benedicic ◽

A. Huell

Keyword(s):

Intraperitoneal Chemotherapy ◽

Gynecologic Oncology ◽

Phase Iii ◽

Stage Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: A Gynecologic Oncology Group study

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70323-3 ◽

2007 ◽

Vol 2007 ◽

pp. 74-76

Author(s):

J.T. Thigpen

Keyword(s):

Intraperitoneal Chemotherapy ◽

Gynecologic Oncology ◽

Phase Iii ◽

Stage Iii ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Phase Iii Trial ◽

Oncology Group Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

816TiP Randomized phase III trial on niraparib - TSR-042 (dostarlimab) vs physician’s choice CHEmotherapy in recurrent ovarian, fallopian tube or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1258 ◽

2021 ◽

Vol 32 ◽

pp. S768-S769

Author(s):

D. Lorusso ◽

L. Musacchio ◽

S. Pignata ◽

E.I. Braicu ◽

D. Cibula ◽

...

Keyword(s):

Cancer Patients ◽

Fallopian Tube ◽

Phase Iii ◽

Phase Iii Trial ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

Download Full-text

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

The Lancet Oncology ◽

10.1016/s1470-2045(13)70363-2 ◽

2013 ◽

Vol 14 (10) ◽

pp. 1020-1026 ◽

Cited By ~ 264

Author(s):

Noriyuki Katsumata ◽

Makoto Yasuda ◽

Seiji Isonishi ◽

Fumiaki Takahashi ◽

Hirofumi Michimae ◽

...

Keyword(s):

Fallopian Tube ◽

Long Term Results ◽

Open Label ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Open Label Trial ◽

Dose Dense ◽

Randomised Controlled

Download Full-text

Quality-of-life outcomes from a randomized phase III trial of dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin as a first-line treatment for stage II–IV ovarian cancer: Japanese Gynecologic Oncology Group Trial (JGOG3016)

Annals of Oncology ◽

10.1093/annonc/mdt527 ◽

2014 ◽

Vol 25 (1) ◽

pp. 251-257 ◽

Cited By ~ 17

Author(s):

K. Harano ◽

F. Terauchi ◽

N. Katsumata ◽

F. Takahashi ◽

M. Yasuda ◽

...

Keyword(s):

Gynecologic Oncology ◽

Phase Iii ◽

Gynecologic Oncology Group ◽

Life Outcomes ◽

First Line ◽

Phase Iii Trial ◽

Dose Dense ◽

Group Trial ◽

First Line Treatment

Download Full-text

AGO-OVAR 16: A phase III study to evaluate the efficacy and safety of pazopanib (PZ) monotherapy versus placebo in women who have not progressed after first line chemotherapy for epithelial ovarian, fallopian tube, or primary peritoneal cancer—Overall survival (OS) results.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.5518 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 5518-5518 ◽

Cited By ~ 4

Author(s):

Ignace Vergote ◽

Lars Christian Hanker ◽

Anne Floquet ◽

Joern Rau ◽

Jae-Weon Kim ◽

...

Keyword(s):

Overall Survival ◽

Fallopian Tube ◽

Phase Iii ◽

Efficacy And Safety ◽

First Line ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer ◽

Phase Iii Study ◽

Line Chemotherapy

Download Full-text